Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 24 May 2019. Rep. Greg Walden.

Executive Summary

US lawmakers and health care experts questioned the idea of requiring device manufacturers to report the value of samples they give away to providers at a 21 May congressional hearing on controlling drug prices and other health-care costs. See what Rep. Greg Walden, R-OR, ranking member of the House Energy and Commerce Committee said about it here.

“These free samples are given to providers to pass on to patients either because they lack insurance, or their insurance doesn’t provide robust coverage of drugs or devices.” –Rep. Greg Walden, ranking member, House Energy and Commerce Committee

Click here for a free trial of Medtech Insight


Related Content

Lawmakers Question Effectiveness Of Free Sample Reporting Requirements





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts